期刊
BLOOD
卷 115, 期 24, 页码 5061-5068出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2009-12-258756
关键词
-
类别
资金
- Swedish Cancer Society
- ALF (Government Public Health Grant) Region Skane
- Goran Gustafsson's Foundation
- Hemato-Linne (Swedish Research Council)
- Torsten o Ragnar Soderbergs Foundation
- Crafoord Foundation
- Medical Research Council [G0501838, G0801073] Funding Source: researchfish
- MRC [G0801073, G0501838] Funding Source: UKRI
Mice deficient in c-fms-like tyrosine kinase 3 (FLT3) signaling have reductions in early multipotent and lymphoid progenitors, whereas no evident myeloid phenotype has been reported. However, activating mutations of Flt3 are among the most common genetic events in acute myeloid leukemia and mice harboring internal tandem duplications within Flt3 (Flt3-ITD) develop myeloproliferative disease, with characteristic expansion of granulocyte-monocyte (GM) progenitors (GMP), possibly compatible with FLT3-ITD promoting a myeloid fate of multipotent progenitors. Alternatively, FLT3 might be expressed at the earliest stages of GM development. Herein, we investigated the expression, function, and role of FLT3 in recently identified early GMPs. Flt3-cre fate-mapping established that most progenitors and mature progeny of the GM lineage are derived from Flt3-expressing progenitors. A higher expression of FLT3 was found in preGMP compared with GMP, and preGMPs were more responsive to stimulationwith FLT3 ligand (FL). Whereas preGMPs and GMPs were reduced in Fl(-/-) mice, megakaryocyte-erythroid progenitors were unaffected and lacked FLT3 expression. Notably, mice deficient in both thrombopoietin (THPO) and FL had a more pronounced GMP phenotype than Thpo(-/-) mice, establishing a role of FL in THPO-dependent and -independent regulation of GMPs, of likely significance for myeloid malignancies with Flt3-ITD mutations. (Blood. 2010;115(24):5061-5068)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据